ArticleHealth science reports2026
Trends and Racial-Geographic Disparities in Coexisting Coronary Artery Disease (CAD) and Heart Failure (HF) Related Mortality Among U.S. Adults, 1999-2024.
Article in Health science reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Coronary artery disease (CAD) and heart failure (HF) frequently coexist, yet national mortality trends capturing both conditions together remain understudied. We examined U.S. mortality trends where CAD and HF coexisted from 1999 to 2024. Methods: We analyzed CDC WONDER multiple-cause-of-death data for adults ≥ 25 years to identify deaths with coexisting CAD and HF. Age-adjusted mortality rates (per 100,000) were standardized to the 2000 U.S. population. Joinpoint regression estimated annual percent changes, and mortality was stratified by demographics, region, and clinical presentation. Results: From 1999 to 2024, 2,930,567 deaths involved coexisting CAD and HF, with 32.82% occurring in inpatient settings. The AAMR declined significantly from 71.6 in 1999 to 43.7 in 2024. Men had higher mortality than women (67.5 vs. 39.8), although declines were steeper in women. White adults had the highest AAMR (52.6), while Asian or Pacific Islanders had the lowest (25.0). The Midwest recorded the highest mortality (54.6), and the Northeast the lowest (47.1). Mortality was higher in rural areas than in urban areas (63.6 vs. 49.5). Older adults had the greatest burden (240.9), whereas younger adults showed increasing trends after 2010. Chronic ischemic cardiomyopathy recorded higher mortality as compared to acute myocardial infarction (9.85 vs. 4.41), although the decline was greater for chronic infarctions. State-level variation was notable, with West Virginia and Oklahoma consistently among the highest. Conclusion: Mortality involving coexisting CAD and HF declined overall but showed persistent demographic and geographic disparities. Targeted prevention strategies are needed to reduce the ischemic HF burden in high-risk populations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.